| 1. Executive Summary |
| 2. India CDMO Market Introduction |
| 2.1. India CDMO Market – Taxonomy |
| 2.2. India CDMO Market –Definitions |
| 2.2.1. By Service |
| 3. India CDMO Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. India CDMO Market Dynamic Factors – Impact Analysis |
| 3.6. India CDMO Market – Competition Landscape |
| 4. India CDMO Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
| 4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. India CDMO Market, By Service, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.1. By CRO |
| 5.1.1. Discovery |
| 5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Preclinical |
| 5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Clinical |
| 5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Laboratory Services |
| 5.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.2. By CMO |
| 5.2.1. Finished Product Manufacturing |
| 5.2.1.1. Injectables |
| 5.2.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.2.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.1.3. Market Opportunity Analysis |
| 5.2.1.2. Solid Dosage Forms |
| 5.2.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.2.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.2.3. Market Opportunity Analysis |
| 5.2.1.3. Others (Semisolids/liquid, powder) |
| 5.2.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.2.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3.3. Market Opportunity Analysis |
| 5.2.2. API Manufacturing |
| 5.2.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. Packaging |
| 5.2.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 6. Competition Landscape |
| 6.1. Strategic Dashboard of Top Market Players |
| 6.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 6.2.1. Albany Molecular Research Inc. (AMRI) |
| 6.2.2. Baxter |
| 6.2.3. Covance Inc. |
| 6.2.4. PAREXEL International Corporation |
| 6.2.5. Pharmaceutical Product Development LLC |
| 6.2.6. Quanticate Ltd. |
| 6.2.7. SGS Life Science Services SA |
| 6.2.8. Thermo Fisher Scientific Inc. (Patheon) |
| 6.2.9. Vetter |
| 6.2.10. Recipharm |
| 7. Research Methodology |
| 8. Key Assumptions and Acronyms |
Request Sample
Request Methodology
Reviews
There are no reviews yet.